High-risk patients exhibited higher proportions of pro-tumor immune cells (M0 macrophages, M2 macrophages, and dendritic cells) and lower proportions of anti-tumor immune cells (M1 macrophages, CD4+ memory T cells, and CD8+ T cells) compared to low-risk patients (Fig. 6D). This evidence concerns the gene CD4 and neoplasm.